As of August 04, 2026, Drugs Made In America Acquisition's top three insider holders are Lynn Stockwell (Ceo And Exe. Chair Of Board, 6.71Mn shares), Made In America Acquisition Ii Llc Drugs (TenPercentOwner, 6.71Mn shares), Catherine Do (Director, 100.00K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Glenn C. Worman | Cfo | 100,000 | 0 | 01 Oct, 2025 |
| Lynn Stockwell | Ceo And Exe. Chair Of Board | 0 | 6,708,333 | 01 Oct, 2025 |
| Sridhar G. Prasad | - | 100,000 | 0 | 01 Oct, 2025 |
| Myron W. Shulgan | - | 100,000 | 0 | 02 Oct, 2025 |
| Catherine Do | - | 100,000 | 0 | 17 Oct, 2025 |
| Made In America Acquisition Ii Llc Drugs | - | 6,708,333 | 0 | 01 Oct, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Sep, 2025 | Catherine Do | Ordinary shares | A | 100,000 | - | 100,000 | D | J |
| 26 Sep, 2025 | Myron W. Shulgan | Ordinary shares | A | 100,000 | - | 100,000 | D | J |
| 26 Sep, 2025 | Myron W. Shulgan | Ordinary shares | A | 100,000 | - | 100,000 | D | J |
| 26 Sep, 2025 | Myron W. Shulgan | Ordinary shares | A | 100,000 | - | 100,000 | D | J |
| 26 Sep, 2025 | Lynn Stockwell | Ordinary shares | A | 700,000 | - | 15,075,000 | I | P |
| 26 Sep, 2025 | Glenn C. Worman | Ordinary shares | A | 100,000 | - | 100,000 | D | J |
| 26 Sep, 2025 | Made In America Acquisition Ii Llc Drugs | Ordinary shares | A | 700,000 | - | 15,075,000 | D | P |
| 26 Sep, 2025 | Sridhar G. Prasad | Ordinary shares | A | 100,000 | - | 100,000 | D | J |
| 26 Sep, 2025 | Lynn Stockwell | Ordinary shares | A | 700,000 | - | 15,075,000 | I | P |
| 26 Sep, 2025 | Made In America Acquisition Ii Llc Drugs | Ordinary shares | A | 700,000 | - | 15,075,000 | D | P |
| 26 Sep, 2025 | Glenn C. Worman | Ordinary shares | A | 100,000 | - | 100,000 | D | J |
| 26 Sep, 2025 | Sridhar G. Prasad | Ordinary shares | A | 100,000 | - | 100,000 | D | J |
| 26 Sep, 2025 | Glenn C. Worman | Ordinary shares | A | 100,000 | - | 100,000 | D | J |
| 26 Sep, 2025 | Lynn Stockwell | Ordinary shares | A | 700,000 | - | 15,075,000 | I | P |
| 26 Sep, 2025 | Sridhar G. Prasad | Ordinary shares | A | 100,000 | - | 100,000 | D | J |
| 26 Sep, 2025 | Made In America Acquisition Ii Llc Drugs | Ordinary shares | A | 700,000 | - | 15,075,000 | D | P |
| 26 Sep, 2025 | Lynn Stockwell | Ordinary shares | D | 400,000 | - | 14,675,000 | I | J |
| 26 Sep, 2025 | Made In America Acquisition Ii Llc Drugs | Ordinary shares | D | 400,000 | - | 14,675,000 | D | J |
| 26 Sep, 2025 | Lynn Stockwell | Ordinary shares | D | 400,000 | - | 14,675,000 | I | J |
| 26 Sep, 2025 | Lynn Stockwell | Ordinary shares | D | 400,000 | - | 14,675,000 | I | J |